v3.26.1
Stock-based Compensation
6 Months Ended
Jun. 28, 2026
Equity [Abstract]  
Stock-based Compensation Stock-based Compensation
Stock-based compensation expense was as follows:
Three Months EndedSix Months Ended
(In millions)June 28, 2026June 29, 2025June 28, 2026June 29, 2025
Cost of sales, excluding amortization of intangibles$1.3 $1.4 $2.3 $2.8 
Selling, marketing and administrative9.9 7.9 18.8 16.1 
Research and development0.8 0.8 1.6 1.6 
Restructuring, integration and other charges— 2.7 — 3.4 
Total stock-based compensation expense$12.0 $12.8 $22.7 $23.9 
The table above includes compensation expense related to liability-classified awards, which has been or is expected to be settled in cash. Amounts related to the three and six months ended June 28, 2026 and June 29, 2025 were not material.
On June 22, 2026, the Board approved and adopted the Company’s 2026 Inducement Plan, effective as of July 15, 2026 (the “Inducement Plan”). The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of the Company, or following a bona-fide period of non-employment, as an inducement material to such individuals entering into employment with the Company, pursuant to Nasdaq Listing Rule 5635(c)(4). The maximum number of shares of the Company’s common stock that may be issued pursuant to awards under the Inducement Plan is 1,000,000. Also on June 22, 2026, the Compensation Committee of the Board approved a one-time inducement sign-on RSU grant (the “Inducement Grant”) to the Company’s new CFO, to be granted on July 15, 2026 with a grant date value of $6.5 million. The Inducement Grant was granted pursuant to the Inducement Plan and as an inducement material to the CFO entering into employment with the Company in accordance with and in reliance upon Nasdaq Listing Rule 5635(c)(4). The Inducement Grant was granted on July 15, 2026, with respect to 356,555 shares and will vest in equal annual installments on the first three anniversaries of the grant date, subject to the CFO's continued employment with the Company through each applicable vesting date